The CEO of Curis Oncology (CRIS) has made his first-ever stock purchases ahead of a major FDA ruling expected by November 30th, signaling high confidence in a positive outcome. For energy exposure, consider MDU Resources (MDU), where the CFO recently made his largest-ever buys and has a perfect one-year track record on previous purchases. A key insider at Pango Therapeutics (PGTX) is making their largest-ever sales after a 250% stock run-up, suggesting a potential price decline. In the housing sector, consider avoiding D.R. Horton (DHI) due to significant insider selling. Instead, research competitors like Resideo Technologies (REZI) and Builders FirstSource (BLDR), which are seeing insider buying.

Curis Oncology (CRIS)

• The CEO has recently purchased the stock for a second time, following a purchase in August.
• This is highly unusual as the CEO has never purchased any stock before in his career, according to the available data.
• His first purchase was followed by a ~20% increase in the stock price.
• The total investment from the CEO is around $700,000.
• Major Catalyst: The company has a significant FDA ruling for a drug approval scheduled to be announced on or before November 30th.

Takeaways

• This is considered a very bullish and compelling signal. An insider making their first-ever stock purchases right before a major, binary event like an FDA ruling suggests a high level of confidence.
• For investors comfortable with the high-risk, high-reward nature of the biotech sector, this insider activity strongly suggests a positive outlook for the upcoming FDA decision.

MDU Resources Group (MDU)

• The CFO recently made two separate open-market purchases of the stock.
• These are the two largest purchases the CFO has ever made.
• The company is in the gas/energy space, a sector noted as having potential political tailwinds.
• The CFO has a strong long-term track record, with a 100% win rate on a one-year timeframe for previous purchases.

Takeaways

• The combination of multiple bullish factors makes this a standout signal.
• Investors looking for exposure to the energy or gas sector should consider moving MDU Resources to the top of their research list. The size of the buys, the insider's track record, and the sector context are all compelling.

ASA Gold and Precious Metals (ASA)

• Saba Capital Management, a 10% owner, has been consistently buying shares and is already profitable on these trades.
• This same insider had "fantastic timing" on a previous purchase when the stock was 50% lower.
• The podcast host noted that they personally copied this trade for gold exposure and are still holding.
• Caveat: Saba is a very frequent trader (over 1,200 trades in the database), which can sometimes dilute the strength of any single trade signal.

Takeaways

• It is a noteworthy bullish signal when a large, sophisticated owner continues to add to their position in a specific theme like gold.
• While the high frequency of their trading adds a layer of caution, their consistent buying and past success with this stock are interesting points for those considering gold-related investments.

Pango Therapeutics (PGTX)

• Third Rock Ventures, a 10% owner, has sold the stock three times in the past few weeks.
• This selling comes after the stock has run up 250% in the last six months.
• This particular insider has a "very good track record" of successfully timing their sales of PGTX stock before price declines.
• The recent sales are their largest individual sales ever, significantly larger than previous transactions.

Takeaways

• This is a notable bearish signal, especially given the stock's massive recent gains.
• Investors should research if there are any upcoming catalysts for the company, such as clinical trial updates or FDA news. The insider selling would suggest a potentially negative outcome for such events.

Sotera Health (SHC)

• Warburg Pincus, a major owner, has been selling shares. The stock is up approximately 30% in the last three months.
• This seller has a good historical track record of timing their sales of SHC stock effectively.
• Another insider also sold shares as part of a secondary offering.

Takeaways

• This is an interesting bearish signal. The combination of a recent run-up in price ("sell the rip") and sales from an insider with a history of good timing is significant.
• Current shareholders might consider whether to trim their position, while potential investors might see this as a reason to avoid the stock for now.

Arista Networks (ANET)

• The CEO has been selling stock via a pre-scheduled 10b5-1 plan.
• However, the size of these sales has "massively increased" recently, with one sale totaling $243 million.
• Historically, when insiders on scheduled plans suddenly make huge sales, it can be a signal of future underperformance over the next 3 to 12 months.

Takeaways

• This is not necessarily a signal that the stock will crash, but it could be a red flag that it may underperform its peers.
• An investor interested in this sector could look for a competing company that does not have similar large-scale insider selling, potentially offering a more confident investment.

D.R. Horton (DHI)

• The Executive Chairman and other insiders have been selling stock.
• This is notable because it is in the housing/builder supply sector, where other companies like Resideo Technologies (REZI) and Builders FirstSource (BLDR) have seen insider buying.
• The recent selling volume at DHI is the highest it has been in the last couple of years.
• The chairman's personal track record of timing sales is mixed.

Takeaways

• This creates a "compare and contrast" opportunity for investors interested in the housing sector.
• The conflicting signals within the same industry can be a useful tool. An investor might favor companies with insider buying (REZI, BLDR) over those with a recent increase in insider selling (DHI).

Dollar Tree (DLTR)

• The CFO bought $340,000 worth of stock. This insider has a strong track record, having previously made a purchase that returned 40% in three months.
• Conflict: At the same time, another insider was selling their shares.

Takeaways

• This is considered a "too hard" situation to analyze.
• When insiders at the same company are buying and selling simultaneously, the signals can cancel each other out, making it difficult to draw a clear conclusion.